CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 1,922 enrolled
Drug / intervention
Rosuvastatin +1 moredrug
Likely dose
Rosuvastatin 20 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01573143
NCT01573143Phase 4Completed
CompareCT.gov

Statin Therapy In Cardiac Surgery

University of Oxford·interventional·Posted Apr 6, 2012·Updated Sep 17, 2014

In Brief

A Phase 4 clinical trial evaluating Rosuvastatin and Placebo for Atrial Fibrillation and Myocardium; Injury. Completed, enrolled 1,922 participants across 1 site.

Detailed Summary

The purpose of STICS trial (Statin Therapy In Cardiac Surgery) is to test whether perioperative treatment with Rosuvastatin 20 mg once daily prevents post-operative atrial fibrillation and reduces perioperative irreversible myocardial damage in patients undergoing elective cardiac surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtrial Fibrillation, Myocardium; Injury
CountriesChina
CollaboratorsChinese Academy of Medical Sciences, Fuwai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College

Timeline

Phase 4CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedApr 6, 2012
Enrollment StartSep 1, 2011
Primary CompletionSep 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 14.2 years ago

Interventions

Rosuvastatindrug

Rosuvastatin (20 mg od) started not earlier than 8 days before surgery and continued until the 5th post-operative day included;

Placebodrug

Placebo started not earlier than 8 days before surgery and continued until the 5th post-operative day included.